Single-Nuclei Transcriptomic Profiling of Human Myocardium in Long-Chain 3-Hydroxyacyl-Coenzyme A Dehydrogenase Deficiency

Read full text Summarise with VIRAT
Authors: Hanna John J Tadros, Diwakar Turaga, Yi Zhao, Chang-Ru Tsai, Lalita Wadhwa, Debra Lynn Kearney, Iki Adachi, Xiao Li, James F. Martin
Cited by: 0
References: 7

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Long chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency (LCHADD) is a rare metabolic disorder that leads to disordered fatty acid oxidation.LCHADD presents as infantile cardiomyopathy in approximately 30% of patients, whom often will go on to develop heart failure (HF) or sudden cardiac arrest.(1)Although early diagnosis, dietary modification, and genotype affects outcomes, the cardiac molecular phenotype remains less understood.A LCHADD patient presented with transient HF at 1 month of life with prototypical symptoms including lactic acidosis and hypoglycemia (Figure 1A).His newborn screen exhibited elevation in long chain fatty acids and genetic testing revealed a pathogenic variant (E510Q) in HADHA.Throughout childhood, he experienced rhabdomyolysis, vomiting, and diarrhea, sometimes accompanied by left ventricle (LV) dysfunction requiring inotropic support.Following three presentations of severe HF at age 14 years, heart transplantation (HTx) was performed due to frequency of HF recurrence.He remained on milrinone for 5 months and normalized function, brain natriuretic peptide, and LV size at time of HTx.

Fields of Study & Subjects

Metabolism and Genetic Disorders Cardiomyopathy and Myosin Studies Cardiovascular Function and Risk Factors

Publication details

Journal / source
Circulation Heart Failure
Volume
19
Issue
5
Pages
e014092–e014092
Publication date
31 March 2026
Language
EN